`
`Inventors: GURNEY el al.
`
`Confirmation No.: 7085
`
`Applicant: OncoMed Pharmaceuticals, Inc.
`
`Art Unit: 1643
`
`Application No.: 15/310,132
`
`Examiner: NATARAJAN, Meera
`
`§ 371(c) Date: November 10, 2016
`
`Atty. Docket: 2293.1220001/PAC/E-H/M-S
`
`Title: Immunotherapy With Binding Agents
`
`Reply to Restriction Requirement and Election of Species
`
`Commissioner for Patents
`
`PO Box 1450
`
`Alexandria, VA 22313-1450
`
`Commissioner:
`
`In reply to the Office Action dated July 2, 2018, requesting an election of one group of
`
`claims to prosecute in the above-referenced patent application, Applicant hereby elects to
`
`prosecute Group II, represented by claims 82-85, 93, and 95. This election is made without
`
`prejudice to or disclaimer of the other claims or inventions disclosed. This election is made
`
`without traverse.
`
`Additionally, the Office has requested several election of species. Specifically:
`
`(2) If Group II or IV is elected, then elect one species from (i) — (v) listed in claim 83.
`
`Regarding species election Group 11, Applicant hereby elects (ii) the IgV-type domain
`
`of VSTM4. Claims 82-85, 93, and 95 read on such species. Applicant believes that the
`
`election of Group II moots the other proposed elections.
`
`
`
`GURNEY el al.
`
`Application No. 15/310,132
`
`These elections are made without prejudice to or disclaimer of the other claims or
`
`inventions disclosed. Applicant asserts the right to claim additional species in the event that a
`
`generic claim thereto is found to be allowable in accordance with 37 C.F.R. § 1.141(a). These
`
`elections are made without traverse.
`
`It is not believed that extensions of time are required beyond those that may otherwise
`
`be provided for in documents accompanying this paper. However, if additional extensions of
`
`time are necessary to prevent abandonment of this application, then such extensions of time
`
`are hereby petitioned under 37 C.F.R. § 1.136(a), and any additional fees required to continue
`
`prosecution or appeal of this application (including issue fee, fees for net addition of claims or
`
`forwarding to appeal) are hereby authorized to be charged to our Deposit Account No. 19-
`
`0036.
`
`Date:
`
`9/4/2018
`
`1100 New York Avenue, NW.
`Washington, DC. 20005-3934
`(202) 371-2600
`
`974719171
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & Fox P.L.L.C.
`
`/Erin J. Heenan/
`
`Erin J. Heenan
`
`Agent for Applicant
`Registration No. 70,012
`
`Atty. Dkt. No. 2293 . 1220001/PAC/E-H/M-S
`
`